(Q24240483)

https://api.crossref.org/works/10.1002%2F14651858.CD007321.PUB2

A simple method for converting an odds ratio to effect size for use in meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007321.PUB2

Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007321.PUB2

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007321.PUB2

S-adenosylmethionine in the treatment of osteoarthritis. Review of the clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007321.PUB2

Identifying relevant studies for systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007321.PUB2

Principles of and Procedures for Systematic Reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007321.PUB2

Efficacy of the dietary supplement S-adenosyl-L-methionine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007321.PUB2

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007321.PUB2

Effects of S-adenosylmethionine on human articular chondrocyte differentiation. An in vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007321.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007321.PUB2

Systematic reviews in health care: Assessing the quality of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007321.PUB2

Osteoarthritis: rational approach to treating the individual

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007321.PUB2

S-adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: a double-blind cross-over trial. [ISRCTN36233495]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007321.PUB2

OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007321.PUB2

Meta-analysis: chondroitin for osteoarthritis of the knee or hip.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007321.PUB2

Undue reliance on I(2) in assessing heterogeneity may mislead

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007321.PUB2

Meta-analysis of the efficacy of adenosylmethionine and oxaceprol in the treatment of osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007321.PUB2

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007321.PUB2

[Double-blind study of SAMe (capsules) and aspirin in osteoarthrosis]

21 January 2018

1 reference

12 December 2020

Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop

1 reference

12 December 2020

Safety and efficacy of S-adenosylmethionine (SAMe) for osteoarthritis

1 reference

12 December 2020

Outcome measurement in osteoarthritis clinical trials

1 reference

12 December 2020

Quantitatively evaluated magnetic resonance tomography as a therapeutic follow-up of the nonsteroidal antirheumatic ademetionin: a pilot study in patients with gonarthrosis

1 reference

12 December 2020

[S-adenosylmethionine (SAMe) in osteoarthrosis; a double-blind crossover peroral study]

1 reference

12 December 2020

Pharmacological and clinical aspects of S-adenosylmethionine (SAMe) in primary degenerative arthropathy (osteoarthrosis)

1 reference

12 December 2020

S-Adenosyl-L-methionine (SAMe): from the bench to the bedside--molecular basis of a pleiotrophic molecule

1 reference

12 December 2020

The effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological study

1 reference

12 December 2020

Double-blind study of S-adenosyl-methionine versus placebo in hip and knee arthrosis

1 reference

12 December 2020

How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study.

1 reference

12 December 2020

Controlled clinical study of SAMe (S-adenosylmethionine) administered orally in degenerative osteoarticular pathology

1 reference

12 December 2020

A double-blind trial of ademetionine vs naproxen in activated gonarthrosis

1 reference

12 December 2020

Double-blind controlled clinical trial of oral S-adenosylmethionine versus piroxicam in knee osteoarthritis

1 reference

12 December 2020

Double-blind clinical trial of S-adenosylmethionine versus ibuprofen in the treatment of osteoarthritis

1 reference

12 December 2020

A randomized, double blind, placebo controlled trial of intravenous loading with S-adenosylmethionine (SAM) followed by oral SAM therapy in patients with knee osteoarthritis

1 reference

12 December 2020

Double-blind multicentre study of the activity of S-adenosylmethionine in hip and knee osteoarthritis

1 reference

12 December 2020

Double-blind comparative clinical trial with S-adenosylmethionine and indomethacin in the treatment of osteoarthritis

1 reference

12 December 2020

[Double-blind clinical study of the therapeutic effect of SAMe and Ibuprofen in degenerative osteoarticular pathology]

1 reference

12 December 2020